HEALTHCARE
Global Bipolar Disorder Treatment Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global Bipolar Disorder Treatment Market, By Type of treatment (Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), and Others), Drug Class (Mood Stabilizers, Antipsychotics, Anti-depressants, Antianxiety Drugs, and Others), Type of Bipolar Disorder (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder, and Others), End User (Hospitals, Specialty Clinics, Mental Health Centers, and Ambulatory Surgical Centers), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
The global Bipolar Disorder Treatment market size is valued to be USD xx million in 2023 and is expected to reach USD xx million by 2032, and it is expected to register a CAGR of xx% over the forecast period 2024-2032.
Bipolar disorder, formerly known as manic-depressive illness, is a mental health condition characterized by extreme mood swings that include emotional highs (mania or hypomania) and lows (depression). These mood swings can vary in intensity and frequency, and they can disrupt daily life and functioning. Treatment for bipolar disorder typically involves a combination of medication, psychotherapy, and lifestyle adjustments. The goals of treatment are to stabilize mood, reduce the frequency and severity of mood episodes (manic, hypomanic, depressive), prevent relapses, and improve overall quality of life. The global bipolar disorder treatment market encompasses pharmaceuticals, psychotherapeutic interventions, and supportive care aimed at managing and alleviating symptoms associated with bipolar disorder.
The respective global report analyses market trends, consumer behaviour and industry dynamics to guide towards entry into new markets with ease. Also, it assists in tailoring market specific and related products and services to meet the needs, preferences, and expectations of target audience by delving into their psychology. The report also specializes with comprehensive and extensive competitive analysis which offers useful insights into competitor strengths, weaknesses, opportunities, and threats. The respective report offers exclusive insights into the potential impact of disruptive developments and technologies that are expected to completely transform corporate operations. The context includes tailor-made research solutions to create a stronger footprint in their particular industries thereby offering dedicated customized solutions according to the client needs which helps in addressing unique business challenges with more simplified and efficient decision-making solutions.
Market Dynamics
DRIVERS
- Rise in frequency of bipolar disorders
- Fast approvals of bipolar disorder therapeutics
RESTRAINTS
- Limited treatment options
- Stigma and lack of mental health awareness
OPPORTUNITIES
- Telepsychiatry and remote care
- Innovative therapies
CHALLENGES
- Adverse effects of medications
- Comorbidity and complexity
SEGMENTATION
- Type of treatment
- Pharmacotherapy
- Psychotherapy
- Electroconvulsive Therapy (ECT)
- Transcranial Magnetic Stimulation (TMS)
- Others
- Drug Class
- Mood Stabilizers
- Antipsychotics
- Anti-depressants
- Antianxiety Drugs
- Others
- Type of Bipolar Disorder
- Bipolar I Disorder
- Bipolar II Disorder
- Cyclothymic Disorder
- Others
- End User
- Hospitals
- Specialty Clinics
- Mental Health Centres
- Ambulatory Surgical Centres
The respective global report is completely customizable specific to regions (North America, Europe, Asia-Pacific, South America, Middle East and Africa), countries, and segments as per the client requirements.
REGIONAL SEGMENTATION
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- Otsuka Pharmaceutical Co., Ltd.
- AstraZeneca plc
- GSK plc
- Pfizer Inc.
- Eli Lilly and Company
- Johnson and Johnson
- AbbVie Inc.
- Novartis AG
- Allergan plc
- Lundbeck A/S
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global Bipolar Disorder Treatment Market, by Type of treatment
- 3.2 Global Bipolar Disorder Treatment Market, by Drug Class
- 3.3 Global Bipolar Disorder Treatment Market, by Type of Bipolar Disorder
- 3.4 Global Bipolar Disorder Treatment Market, by End User
- 3.5 Global Bipolar Disorder Treatment Market, by Geography
- 3.6 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Global mental health initiatives
- 5.1.2 Focus on early intervention and prevention
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Rise in frequency of bipolar disorders
- 5.2.2 Fast approvals of bipolar disorder therapeutics
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 Limited treatment options
- 5.3.2 Stigma and lack of mental health awareness
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Telepsychiatry and remote care
- 5.4.2 Innovative therapies
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Adverse effects of medications
- 5.5.2 Comorbidity and complexity
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL BIPOLAR DISORDER TREATMENT MARKET, BY TYPE OF TREATMENT
- 6.1 Type of treatment Summary
- 6.2 Market Attractive Index
- 6.3 Global Bipolar Disorder Treatment Market, by Type of treatment (2019-2032)
- SECTION 7 - GLOBAL BIPOLAR DISORDER TREATMENT MARKET, BY DRUG CLASS
- 7.1 Drug Class Summary
- 7.2 Market Attractive Index
- 7.3 Global Bipolar Disorder Treatment Market, by Drug Class (2019-2032)
- SECTION 8 - GLOBAL BIPOLAR DISORDER TREATMENT MARKET, BY TYPE OF BIPOLAR DISORDER
- 8.1 Type of Bipolar Disorder Summary
- 8.2 Market Attractive Index
- 8.3 Global Bipolar Disorder Treatment Market, by Type of Bipolar Disorder (2019-2032)
- SECTION 9 - GLOBAL BIPOLAR DISORDER TREATMENT MARKET, BY END USER
- 9.1 End User Summary
- 9.2 Market Attractive Index
- 9.3 Global Bipolar Disorder Treatment Market, by End User (2019-2032)
- SECTION 10 - GLOBAL BIPOLAR DISORDER TREATMENT MARKET, BY GEOGRAPHY
- 10.1 Regional Summary
- 10.2 Market Attractive Index
- 10.3 Global Bipolar Disorder Treatment Market, by Geography (2019-2032)
- SECTION 11 - NORTH AMERICA BIPOLAR DISORDER TREATMENT MARKET
- 11.1 North America Summary
- 11.2 Market Attractive Index
- 11.3 North America Bipolar Disorder Treatment Market, by Type of treatment (2019-2032)
- 11.4 North America Bipolar Disorder Treatment Market, by Drug Class (2019-2032)
- 11.5 North America Bipolar Disorder Treatment Market, by Type of Bipolar Disorder (2019-2032)
- 11.6 North America Bipolar Disorder Treatment Market, by End User (2019-2032)
- 11.7 North America Bipolar Disorder Treatment Market, by Country (2019-2032)
- 11.7.1 U.S.
- 11.7.2 Canada
- 11.7.3 Mexico
- 11.7.4 Rest of North America
- SECTION 12 - EUROPE BIPOLAR DISORDER TREATMENT MARKET
- 12.1 Europe Summary
- 12.2 Market Attractive Index
- 12.3 Europe Bipolar Disorder Treatment Market, by Type of treatment (2019-2032)
- 12.4 Europe Bipolar Disorder Treatment Market, by Drug Class (2019-2032)
- 12.5 Europe Bipolar Disorder Treatment Market, by Type of Bipolar Disorder (2019-2032)
- 12.6 Europe Bipolar Disorder Treatment Market, by End User (2019-2032)
- 12.7 Europe Bipolar Disorder Treatment Market, by Country (2019-2032)
- 12.7.1 Germany
- 12.7.2 U.K.
- 12.7.3 France
- 12.7.4 Italy
- 12.7.5 Spain
- 12.7.6 Russia
- 12.7.7 The Netherlands
- 12.7.8 Belgium
- 12.7.9 Turkey
- 12.7.10 Rest of Europe
- SECTION 13 - ASIA-PACIFIC BIPOLAR DISORDER TREATMENT MARKET
- 13.1 Asia-Pacific Summary
- 13.2 Market Attractive Index
- 13.3 Asia-Pacific Bipolar Disorder Treatment Market, by Type of treatment (2019-2032)
- 13.4 Asia-Pacific Bipolar Disorder Treatment Market, by Drug Class (2019-2032)
- 13.5 Asia-Pacific Bipolar Disorder Treatment Market, by Type of Bipolar Disorder (2019-2032)
- 13.6 Asia-Pacific Bipolar Disorder Treatment Market, by End User (2019-2032)
- 13.7 Asia-Pacific Bipolar Disorder Treatment Market, by Country (2019-2032)
- 13.7.1 China
- 13.7.2 India
- 13.7.3 Japan
- 13.7.4 South Korea
- 13.7.5 Singapore
- 13.7.6 Malaysia
- 13.7.7 Australia
- 13.7.8 Thailand
- 13.7.9 Philippines
- 13.7.10 Rest of Asia-Pacific
- SECTION 14 - SOUTH AMERICA BIPOLAR DISORDER TREATMENT MARKET
- 14.1 South America Summary
- 14.2 Market Attractive Index
- 14.3 South America Bipolar Disorder Treatment Market, by Type of treatment (2019-2032)
- 14.4 South America Bipolar Disorder Treatment Market, by Drug Class (2019-2032)
- 14.5 South America Bipolar Disorder Treatment Market, by Type of Bipolar Disorder (2019-2032)
- 14.6 South America Bipolar Disorder Treatment Market, by End User (2019-2032)
- 14.7 South America Bipolar Disorder Treatment Market, by Country (2019-2032)
- 14.7.1 Brazil
- 14.7.2 Argentina
- 14.7.3 Chile
- 14.7.4 Colombia
- 14.7.5 Rest of South America
- SECTION 15 - MIDDLE EAST AND AFRICA BIPOLAR DISORDER TREATMENT MARKET
- 15.1 Middle East and Africa Summary
- 15.2 Market Attractive Index
- 15.3 Middle East and Africa Bipolar Disorder Treatment Market, by Type of treatment (2019-2032)
- 15.4 Middle East and Africa Bipolar Disorder Treatment Market, by Drug Class (2019-2032)
- 15.5 Middle East and Africa Bipolar Disorder Treatment Market, by Type of Bipolar Disorder (2019-2032)
- 15.6 Middle East and Africa Bipolar Disorder Treatment Market, by End User (2019-2032)
- 15.7 Middle East and Africa Bipolar Disorder Treatment Market, by Country (2019-2032)
- 15.7.1 Kingdom of Saudi Arabia
- 15.7.2 South Africa
- 15.7.3 U.A.E.
- 15.7.4 Egypt
- 15.7.5 Rest of Middle East and Africa
- SECTION 16 - COMPANY SHARE ANALYSIS
- 16.1 Global Bipolar Disorder Treatment Market, Company Share Analysis
- 16.2 North America Bipolar Disorder Treatment Market, Company Share Analysis
- 16.3 Europe Bipolar Disorder Treatment Market, Company Share Analysis
- 16.4 Asia-Pacific Bipolar Disorder Treatment Market, Company Share Analysis
- SECTION 17 - COMPANY PROFILES
- 17.1 Otsuka Pharmaceutical Co., Ltd.
- 17.1.1 Company Snapshot
- 17.1.2 Financial Overview
- 17.1.3 Product Portfolio
- 17.1.4 Recent Developments
- 17.2 AstraZeneca plc
- 17.2.1 Company Snapshot
- 17.2.2 Financial Overview
- 17.2.3 Product Portfolio
- 17.2.4 Recent Developments
- 17.3 GSK plc
- 17.3.1 Company Snapshot
- 17.3.2 Financial Overview
- 17.3.3 Product Portfolio
- 17.3.4 Recent Developments
- 17.4 Pfizer Inc.
- 17.4.1 Company Snapshot
- 17.4.2 Financial Overview
- 17.4.3 Product Portfolio
- 17.4.4 Recent Developments
- 17.5 Eli Lilly and Company
- 17.5.1 Company Snapshot
- 17.5.2 Financial Overview
- 17.5.3 Product Portfolio
- 17.5.4 Recent Developments
- 17.6 Johnson and Johnson
- 17.6.1 Company Snapshot
- 17.6.2 Financial Overview
- 17.6.3 Product Portfolio
- 17.6.4 Recent Developments
- 17.7 AbbVie Inc.
- 17.7.1 Company Snapshot
- 17.7.2 Financial Overview
- 17.7.3 Product Portfolio
- 17.7.4 Recent Developments
- 17.8 Novartis AG
- 17.8.1 Company Snapshot
- 17.8.2 Financial Overview
- 17.8.3 Product Portfolio
- 17.8.4 Recent Developments
- 17.9 Allergan plc
- 17.9.1 Company Snapshot
- 17.9.2 Financial Overview
- 17.9.3 Product Portfolio
- 17.9.4 Recent Developments
- 17.10 Lundbeck A/S
- 17.10.1 Company Snapshot
- 17.10.2 Financial Overview
- 17.10.3 Product Portfolio
- 17.10.4 Recent Developments
- SECTION 18 - RELATED REPORTS
- SECTION 19 - DISCLAIMER
RESEARCH METHODOLOGY
The research methodology employed in Uniprism Market Research involves four basic steps namely research and data collection, data pre-processing, modeling and forecasting, quality assurance and output.
RESEARCH AND DATA COLLECTION
A tripod model research technique is followed for research and data collection in which various approaches such as primary research, secondary research, and product mapping are considered.
Primary research basically involves the process of conducting personalized interviews with market related professionals of major market players, investors, distributors, vendors and many more.
The secondary research include data published by government, annual reports, press releases, investor presentations of companies, white papers, certified publications, annual manufacturing limit of the respective industries related to the market, production consumption analysis of certain products respective to the market and many more.
Below mention are few of the sources which we have considered while estimating the market size:
For instance,
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
Product mapping means the process of mapping the list of products that a key player contributes to the market as well as estimating the revenue of those products in order to define the Global Company share analysis of the respective Global Company in global, regional, and country level markets.
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
The process of developing mathematical, statistical, or computational representations of real-world occurrences or relationships is known as modelling. These models are intended to replicate and explain market interactions, interdependence, and dynamics. These models are used by Uniprism Market Research to acquire a better knowledge of numerous market characteristics such as customer preferences, pricing elasticity, competition dynamics, and more. Depending on the individual study aims, many types of models are utilized, such as regression models, econometric models, decision tree models, and machine learning models.
Forecasting is the process of predicting future market conditions, trends, and occurrences using past data and models. Forecasting is used by Uniprism Market Research to estimate future sales, demand for products or services, market growth, and other important performance metrics. Forecasting accurately can assist organizations in making educated decisions about resource allocation, pricing, inventory management, and marketing tactics.
We create standardized bottom-up or top-down models that scale by leveraging data science and machine learning technology. All our market models consider the unique market characteristics of each country. Forecasting is based on major market indicators and a combination of traditional methodologies, such as exponential smoothing, time series analysis, regression analysis, and more modern techniques such as machine learning algorithms are all forecasting methodologies. The method chosen is determined on the nature of the data and the specific forecasting aims.
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.